Iovance Biotherapeutics, Inc. (IOVA)
3.525
-0.56
(-13.81%)
USD |
NASDAQ |
May 07, 15:43
Iovance Biotherapeutics SG&A Expense (TTM) : 152.58M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Orthofix Medical, Inc. | 421.35M |
| InfuSystem Holdings, Inc. | 67.46M |
| Axogen, Inc. | 153.32M |
| Avanos Medical, Inc. | 239.90M |
| KalVista Pharmaceuticals, Inc. | 191.34M |